subscription-model publication for all. While the move will undoubtedly be startling to some longtime users, the evolution marks a financially sound way for us to continue to deliver robust content that is relevant to the field and to our readers.
I have long felt ambivalent about advertising, especially from pharmaceutical or device companies. On the positive side, advertising can provide needed information and attention to new products for clinicians. On the negative side, the ultimate purpose of advertising is to persuade and influence clinicians who are susceptible to advertisers' siren song to prescribe more of the advertisers' products. While the content of Psychiatric Annals has always maintained its emphatic independence from advertisers, becoming a paid product for all allows our editorial team to take this tenuous relationship out of the equation. It allows us to renew our focus on giving readers the valuable information they need most.
For a limited time, in appreciation of our controlled circulation's many decades of readership, individual subscribers will have the opportunity to earn unlimited free Psychiatric Annals' CME credits while they are actively subscribed. Whereas our publisher previously charged for CME credits, now individual paid subscribers will be able to access this valuable content free whenever they desire, from the comfort of their desktops, tablets, phones, even in print. I am highly optimistic about moving from controlled circulation to a fee-based journal with free CME; we have brought high value content to the mental health community for decades and we will continue to do so for decades to come.
As we evolve, we thank you for your support. We value your feedback and your continued readership.
